Using Tefillin to Protect Heart Function in Women
Acute and Chronic Effects of Tefillin Use on Remote Cardiac Ischemic Preconditioning
NA · University of Cincinnati · NCT06390358
This study tests if wearing tefillin can help protect the hearts of women at risk for heart attacks by reducing damage when blood flow is restored after an attack.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 24 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | University of Cincinnati (other) |
| Locations | 1 site (Cincinnati, Ohio) |
| Trial ID | NCT06390358 on ClinicalTrials.gov |
What this trial studies
This study investigates the effects of remote ischemic preconditioning (RIPC) through the non-obstructive wearing of tefillin on women at risk for heart attacks. It aims to determine whether this method can induce a protective response against reperfusion injury, which occurs when blood flow is restored after a heart attack. The study will measure heart rate variability and inflammatory markers to assess the effectiveness of this approach. The research builds on previous findings in men and seeks to translate these insights to a female population.
Who should consider this trial
Good fit: Ideal candidates for this study are healthy women over 18 years of age.
Not a fit: Patients currently taking medication for a medical condition or those with active medical conditions may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could provide a novel, non-invasive method to protect women's heart function during and after heart attacks.
How similar studies have performed: While previous studies have shown promise in men, this specific approach in women is novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Females over 18 years of age Exclusion Criteria: * Current medication use for medical condition or active medical condition
Where this trial is running
Cincinnati, Ohio
- University of Cincinnati — Cincinnati, Ohio, United States (RECRUITING)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Cardiac Function and Preconditioning